glp-1 receptor agonists for type 2 diabetes Targeting GLP-1, GIP & GCG

EZ-482 Based on 1 publication(s) in Google Scholar EZ-482, a novel ligand of apolipoprotein (apoE) , binds to sites on apoE in the C-terminal domain with K d s of 5-10 M for apoE3 and apoE4

Total thiols 5-Chloromethylfluorescein diacetate (5-CMFDA) [482]

Metabolites of purine nucleoside phosphorylase (NP) in serum have the potential to delineate pancreatic adenocarcinoma

The peptide must survive the acidic cauldron of the stomach, navigate the enzyme-rich small intestine, and then be absorbed through the intestinal wall to enter the portal vein

Once-daily liraglutide versus lixisenatide as add-on to metformin in type 2 diabetes: a 26-week randomized controlled clinical trial